Ambrisentan Tablets and Buprenorphine Extended-Release Injection
Determining the interaction of Ambrisentan Tablets and Buprenorphine Extended-Release Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ambrisentan
Brand name: Letairis
Synonyms: Ambrisentan
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ambrisentan Tablets-Buprenorphine implant
- Ambrisentan Tablets-Buprenorphine Injection
- Ambrisentan Tablets-Buprenorphine injection - Buprenex
- Ambrisentan Tablets-Buprenorphine injection - Sublocade
- Ambrisentan Tablets-Buprenorphine Intradermal
- Ambrisentan Tablets-Buprenorphine oral/buccal
- Buprenorphine Extended-Release Injection-Amcinonide
- Buprenorphine Extended-Release Injection-Amcinonide Cream and Ointment
- Buprenorphine Extended-Release Injection-Amcinonide Lotion
- Buprenorphine Extended-Release Injection-Amcinonide Ointment
- Buprenorphine Extended-Release Injection-Amcinonide topical
- Buprenorphine Extended-Release Injection-Amcinonide Topical application